Research into glioblastoma remains critical as there is no cure, and recent funding cuts pose significant threats to ongoing efforts. The ACSCAN highlighted alarming budget reductions, including a 57% cut to cancer program spending. With glioblastoma, kidney, lung, and pancreatic cancers receiving no funding under new resolutions, advocates like Lisa Lacasse emphasize the importance of public support for cancer research. Additionally, cuts at the NIH raise concerns about the sustainability of cancer research initiatives amidst already present challenges.
There is no known cure for glioblastoma; however, research shows it is possible to shrink tumors and prolong patients' lifespans, highlighting the need for continued funding.
Last month, Congress passed a bill leading to a staggering 57% cut to the Congressionally Directed Medical Research Programs, impacting critical cancer research funding.
ACSCAN President Lisa Lacasse expressed gratitude to Meghan McCain for raising awareness about cancer research funding, urging Americans to advocate against such severe budget cuts.
Cancer researchers are concerned about job cuts at the NIH and other health agencies, announced by HHS, which could endanger the future of cancer research.
Collection
[
|
...
]